Results 51 to 60 of about 5,800 (169)
Use of natamycin and ketoconazole suppositories in the treatment of recurrent vulvovaginal candidiasis [PDF]
Use of natamycin and ketoconazole suppositories in the treatment of recurrent vulvovaginal candidiasis I.I. Ivanova1, Yu.E. Dobrokhotova2 1 Pirogov Russian National Research Medical University, Moscow, Russian Federation 2 Clinical ...
I.I. Ivanova, Yu.E. Dobrokhotova
doaj
Bimekizumab efficacy and safety in Chinese patients with psoriasis in the BE SHINING Phase 3 study
In Chinese patients with moderate to severe plaque psoriasis, bimekizumab treatment was well tolerated and led to significantly higher clinical response rates versus placebo, including complete skin clearance. These findings were consistent with global studies and suggest that bimekizumab is an effective treatment option for Chinese people living with ...
Lin Cai +11 more
wiley +1 more source
This review focuses on vulvovaginal candidiasis (VVC), examining its epidemiology, the pathogenesis of Candida albicans, and its relationships with vaginal microbiota. It comprehensively reviews probiotic‐based management strategies and their mechanisms of action, and concludes by discussing current limitations, challenges and future research ...
Tong Chen +13 more
wiley +1 more source
Safety and Efficacy of a 24‐Cycle Administration of a Drospirenone‐Only Pill in Japanese Women
ABSTRACT Aim We conducted a 24‐cycle study to evaluate long‐term safety of 4 mg of drospirenone (DRSP), a progestin‐only pill (POP), for contraception in Japanese women. Methods A multicenter, single‐arm 24‐cycle study was conducted in women who participated in the 13 cycle study of DRSP.
Kunio Kitamura +5 more
wiley +1 more source
Clotrimazole‐loaded PLGA microparticles for local drug delivery to the vagina: Shape does matter
Clotrimazole‐loaded PLGA microparticles for intravaginal delivery. Abstract Background Intravaginal drug administration is the most promising strategy for treating vaginal infections to protect women's health, such as vulvovaginal candidiasis (VVC). However, conventional vaginal formulations in the clinic face challenges such as drug leakage and low ...
Yanyu Li +8 more
wiley +1 more source
Vulvovaginal candidiasis [PDF]
D, Moreira, C R, Paula
openaire +4 more sources
Pathogenetic aspects and modern possibilities of therapy of vulvovaginal candidiasis [PDF]
The literature review presents modern aspects of the etiology and pathogenesis of vulvovaginal candidiasis, highlights issues of immunological resistance and the significance of polymorphic and pathological gene loci, the functioning of which leads to ...
Margarita R. Rakhmatulina +2 more
doaj +1 more source
Gynecologic conditions in the context of incarceration: A scoping review
Abstract Background More than 740 000 people identified as female at intake were incarcerated globally as of 2022, reflecting a 60% global increase since the year 2000, with a concomitant increase in gynecologic conditions experienced behind bars.
Meredith K. Wise +6 more
wiley +1 more source
Treatment of recurrent vulvovaginal candidiasis in women planning a pregnancy [PDF]
Treatment of recurrent vulvovaginal candidiasis in women planning a pregnancy Borovikov I.O., Kutsenko I.I., Gerasimenko E.E. Kuban State Medical University, Krasnodar Aim: evaluation of treatment methods for recurrent vulvovaginal candidiasis ...
Borovikov I.O. +2 more
doaj
Heparan Sulfate Proteoglycans in Immunity
ABSTRACT In immune cells, heparin was first identified in mast cells in the 1940s, followed by the discovery of heparan sulfate in lymphocytes and granulocytes during the 1970s and 1980s. Subsequent decades of research have revealed how heparan sulfate and heparin, conjugated to core proteins as heparan sulfate proteoglycans (HSPGs), act as versatile ...
Moe Iwai, Pyong Woo Park
wiley +1 more source

